Alset Inc. (NASDAQ:AEI – Get Free Report) was the recipient of a large decline in short interest in November. As of November 15th, there was short interest totalling 1,400 shares, a decline of 89.2% from the October 31st total of 13,000 shares. Based on an average daily trading volume, of 41,500 shares, the short-interest ratio is currently 0.0 days. Approximately 0.1% of the shares of the company are sold short.
Alset Stock Performance
AEI opened at $1.21 on Thursday. Alset has a fifty-two week low of $0.46 and a fifty-two week high of $2.05. The stock has a market cap of $11.18 million, a price-to-earnings ratio of -0.28 and a beta of 1.26. The firm’s fifty day moving average is $1.40 and its 200 day moving average is $1.20.
Insider Activity
In other news, Director Heng Fai Ambrose Chan acquired 4,411,764 shares of Alset stock in a transaction dated Monday, November 25th. The stock was purchased at an average cost of $0.68 per share, with a total value of $2,999,999.52. Following the completion of the purchase, the director now directly owns 11,387,954 shares in the company, valued at approximately $7,743,808.72. This trade represents a 63.24 % increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Insiders own 66.70% of the company’s stock.
Alset Company Profile
Alset Inc engages in the real estate development, financial services, digital transformation technologies, biohealth activities, and consumer products businesses in the United States, Singapore, Hong Kong, Australia, and South Korea. It operates through four segments: Real Estate, Digital Transformation Technology, Biohealth, and Other Business Activities segments.
Featured Stories
- Five stocks we like better than Alset
- Stock Market Sectors: What Are They and How Many Are There?
- Microsoft Stock Gets a $550 Price Target: Time to Get Excited
- Investing in Construction Stocks
- Trump Tariffs in Focus: 2 Chinese Stocks to Own and 2 to Avoid
- Transportation Stocks Investing
- 2 Generic Drug Stocks Ready to Surge in 2025
Receive News & Ratings for Alset Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alset and related companies with MarketBeat.com's FREE daily email newsletter.